Latest Capital Raise News

Papyrus Australia has appointed Daniel Schmidt as CEO and secured a $250k government grant alongside a binding agreement to produce biodegradable mining products, marking a decisive shift from R&D to commercial operations.

Sprintex Limited has raised $1.5 million through a strategic placement to advance its ammonia-reduction technology in Europe, supported by pending orders worth €9.3 million. The funding underscores growing investor confidence amid tightening environmental regulations.

Tungsten Mining NL has successfully raised $9.5 million through a share placement to advance its Mt Mulgine gold-tungsten project, reinforcing its position in the global tungsten market.

Metal Bank Limited has announced a non-renounceable entitlement offer to raise approximately $2.32 million, partially underwritten, to fund its Western Australia gold strategy and Queensland graphite exploration. The offer closes on 31 October 2025 and coincides with a strategic acquisition of gold assets from Hastings Technology Metals.

Anteris Technologies has gained shareholder approval for an ASX waiver allowing flexible capital raising and updated its PARADIGM trial timeline, now set to begin patient enrolment in Q4 2025 after addressing FDA requests.

Buru Energy reminds shareholders that its Share Purchase Plan closes on 7 October, offering shares at 2 cents each plus attaching options subject to approval.

Variscan Mines has successfully completed the majority of the second tranche of its $2.5 million capital raise, issuing over 330 million shares and nearly 200 million options to support its zinc-lead project in Spain.

Locksley Resources has completed its second tranche placement with Tribeca, significantly strengthening its cash reserves to support its U.S. mine-to-market ambitions.

Altamin Limited has launched a $6.46 million retail entitlement offer to fund exploration at its Lazio Project and maintain the Gorno Project. Eligible shareholders can subscribe to new shares at $0.025 each on a 45-for-100 basis.

Altamin Limited has launched a $6.46 million accelerated entitlement offer to fund exploration at its Lazio and Gorno projects, while excluding shareholders in certain jurisdictions due to regulatory constraints.

Altamin Limited has initiated a 45 for 100 accelerated pro-rata entitlement offer at $0.025 per share to raise up to AUD 6.46 million, supporting its Lazio and Gorno projects in Italy. The offer includes a strong institutional backing and opens to eligible retail shareholders across multiple jurisdictions.

Imagion Biosystems has completed the second tranche of its $3.5 million placement, raising $2.85 million to advance its proprietary MagSense® imaging technology targeting breast, prostate, and ovarian cancers.